# Tünde Pető

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tunde-peto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,330 |
| Field | Retinal Diseases and Treatments |
| h-index | 72 |
| i10-index | 345 |
| Last Known Institution | Queen's University Belfast |
| OpenAlex ID | https://openalex.org/A5018227698 |
| ORCID iD | https://orcid.org/0000-0001-6265-0381 |
| Works | 839 |

## Researcher papers

- [Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis](https://scholariq.org/papers/global-causes-of-blindness-and-distance-vision-impairment-1990-2020-a-systematic/)
- [Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis](https://scholariq.org/papers/magnitude-temporal-trends-and-projections-of-the-global-prevalence-of-blindness/)
- [The Lancet Global Health Commission on Global Eye Health: vision beyond 2020](https://scholariq.org/papers/the-lancet-global-health-commission-on-global-eye-health-vision-beyond-2020/)
- [A foundation model for generalizable disease detection from retinal images](https://scholariq.org/papers/a-foundation-model-for-generalizable-disease-detection-from-retinal-images/)
- [A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)](https://scholariq.org/papers/a-prospective-randomized-trial-of-intravitreal-bevacizumab-or-laser-therapy-in/)
- [A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema](https://scholariq.org/papers/a-2-year-prospective-randomized-controlled-trial-of-intravitreal-bevacizumab-or/)
- [Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/eplerenone-for-chronic-central-serous-chorioretinopathy-in-patients-with-active/)
- [Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings](https://scholariq.org/papers/systematic-review-on-barriers-and-enablers-for-access-to-diabetic-retinopathy/)

## Researcher topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal Imaging and Analysis](https://scholariq.org/topics/retinal-imaging-and-analysis/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Retinal and Optic Conditions](https://scholariq.org/topics/retinal-and-optic-conditions/)

## Researcher university

- [Queen's University Belfast](https://scholariq.org/institutions/queen-s-university-belfast/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.